IN2014CH00518A - - Google Patents

Download PDF

Info

Publication number
IN2014CH00518A
IN2014CH00518A IN518CH2014A IN2014CH00518A IN 2014CH00518 A IN2014CH00518 A IN 2014CH00518A IN 518CH2014 A IN518CH2014 A IN 518CH2014A IN 2014CH00518 A IN2014CH00518 A IN 2014CH00518A
Authority
IN
India
Prior art keywords
formula
compound
bzo
deoxy
fluoro
Prior art date
Application number
Other languages
English (en)
Inventor
Thirumalai Rajan Srinivasan
Kishore Kumar Muppa
Srinivas Rao Nimmala
Original Assignee
Msn Lab Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msn Lab Private Ltd filed Critical Msn Lab Private Ltd
Priority to PCT/IN2015/000068 priority Critical patent/WO2015118558A2/en
Priority to IN518CH2014 priority patent/IN2014CH00518A/en
Publication of IN2014CH00518A publication Critical patent/IN2014CH00518A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
IN518CH2014 2014-02-04 2015-02-04 IN2014CH00518A (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2015/000068 WO2015118558A2 (en) 2014-02-04 2015-02-04 Process for the preparation of clofarabine
IN518CH2014 IN2014CH00518A (pl) 2014-02-04 2015-02-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN518CH2014 IN2014CH00518A (pl) 2014-02-04 2015-02-04

Publications (1)

Publication Number Publication Date
IN2014CH00518A true IN2014CH00518A (pl) 2015-08-07

Family

ID=53778571

Family Applications (1)

Application Number Title Priority Date Filing Date
IN518CH2014 IN2014CH00518A (pl) 2014-02-04 2015-02-04

Country Status (2)

Country Link
IN (1) IN2014CH00518A (pl)
WO (1) WO2015118558A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105601688A (zh) * 2015-12-23 2016-05-25 国药一心制药有限公司 一种氯法拉滨中间体及氯法拉滨的制备方法
CN106397518B (zh) * 2016-10-18 2019-05-17 武汉百科药物开发有限公司 一种氯法拉滨的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4555536B2 (ja) * 2000-02-18 2010-10-06 サザン・リサーチ・インスティテュート 2−クロロ−9−(2−デオキシ−2−フルオロ−β−D−アラビノフラノシル)−9H−プリン−6−アミンの合成方法
ES2306783T3 (es) * 2001-08-02 2008-11-16 Ilex Oncology, Inc. Procedimiento para preparar nucleosidos purinicos.
CN101555267A (zh) * 2008-04-09 2009-10-14 杭州容立医药科技有限公司 一种核苷酸类似物克罗拉滨的合成方法
CN101265284B (zh) * 2008-05-07 2011-04-27 深圳万乐药业有限公司 氯法拉滨的合成方法

Also Published As

Publication number Publication date
WO2015118558A2 (en) 2015-08-13
WO2015118558A3 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
MX2022015612A (es) Nucleotidos de purina beta-d-2'-desoxi-2'-alfa-fluoro-2'-beta-c-su stituidos-2-modificados-n6-sustituidos para el tratamiento del virus de la hepatitis c.
PH12018500856A1 (en) Respiratory syncytial virus vaccine
EP4424835A3 (en) Compositions and methods for synthesizing 5'-capped rnas
EP4349405A3 (en) Respiratory virus vaccines
AR108263A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
EP3330277A3 (en) Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
JP2016525888A5 (pl)
BR112013018975A2 (pt) processo para o preparo de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos
HK1224229A1 (zh) 取代的核苷,核苷酸及其类似物
AR088109A1 (es) Metodo para preparar analogos nucleotidicos antivirales
LT3512863T (lt) 2'-pakeistieji-n6-pakeistieji purino nukleotidai, skirti gydymui rnr virusu
WO2012118972A3 (en) Process of preparing guanylate cyclase c agonists
MX2017010195A (es) Sal de un compuesto de pirimido [6,1-a]isoquinolin-4-ona.
EA034882B9 (ru) Способ синтеза полинуклеотида
MY173068A (en) Stripping compositions having high wn/w etching selectivity
BR112017020380A2 (pt) processo para separar hidrocarbonetos de uma solução compreendendo um polímero
WO2016166720A3 (en) Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives
BR112016030604B8 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos
ZA202405277B (en) Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
PH12016501808A1 (en) Chemical compounds
MX2017016108A (es) Capsulas de capecitabina de liberacion prolongada.
WO2016202808A3 (en) NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES
WO2016059646A3 (en) Improved process for the preparation of 4- [6-amino-5-bromo-2- [(4-cvanophenyl) aminol]-4-pvrimidinvl]oxv]-3.5-dimethvlbenzonitrile
CL2017003172A1 (es) Método para producir cianuro de sodio
CL2011000717A1 (es) Compuesto derivado de fosforamidato de nucleosido de purina, un hidrato o solvato del mismo; composicion que lo comprende; proceso de preparacion, util para el tratamiento de la infeccion por el virus de la hepatitis c (vhc).